Stockreport

Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum's Degrader–Antibody Conjugate Payload Platforms and Expand TPD²® Therapeutic Applications [Yahoo!...

Mersana Therapeutics, Inc.  (MRSN) 
Last mersana therapeutics, inc. earnings: 2/28 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana
PDF the "Company") (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Dorin Toader [Read more]